APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptic Ulcers Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Peptic Ulcers Treatment Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchPeptic Ulcers Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptic Ulcers Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Peptic Ulcers Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptic Ulcers Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptic Ulcers Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Peptic Ulcers Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Peptic Ulcers Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Peptic Ulcers Treatment market include Ache Laboratorios Farmaceuticos S/A, Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industry Co., Ltd., RaQualia Pharma Inc., Sequella, Inc., Sihuan Pharmaceutical Holdings Group Ltd. and Sinil Pharmaceutical Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Peptic Ulcers Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptic Ulcers Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptic Ulcers Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Peptic Ulcers Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptic Ulcers Treatment Segment by Company

Ache Laboratorios Farmaceuticos S/A

Astellas Pharma Inc.

ChoDang Pharm Co., Ltd.

Daewoong Pharmaceutical Co., Ltd.

Kukje Pharmaceutical Industry Co., Ltd.

RaQualia Pharma Inc.

Sequella, Inc.

Sihuan Pharmaceutical Holdings Group Ltd.

Sinil Pharmaceutical Co., Ltd

Yooyoung Pharmaceutical Co., Ltd

Peptic Ulcers Treatment Segment by Type

DWP-14012

DWJ-206

BGC-001

ASP-6537

Others

Peptic Ulcers Treatment Segment by Application

Hospital

Clinic

Others

Peptic Ulcers Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Peptic Ulcers Treatment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Peptic Ulcers Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Peptic Ulcers Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Peptic Ulcers Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcers Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Peptic Ulcers Treatment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptic Ulcers Treatment industry.

Chapter 3: Detailed analysis of Peptic Ulcers Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Peptic Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Peptic Ulcers Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Peptic Ulcers Treatment Industry Trends Table 2. Peptic Ulcers Treatment Industry Drivers Table 3. Peptic Ulcers Treatment Industry Opportunities and Challenges Table 4. Peptic Ulcers Treatment Industry Restraints Table 5. Global Peptic Ulcers Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Peptic Ulcers Treatment Revenue Share by Company (2021-2026) Table 7. Global Peptic Ulcers Treatment Sales Volume by Company (k units) & (2021-2026) Table 8. Global Peptic Ulcers Treatment Sales Volume Share by Company (2021-2026) Table 9. Global Peptic Ulcers Treatment Average Price (US$/unit) of Company (2021-2026) Table 10. Global Peptic Ulcers Treatment Company Ranking, (2024-2026) & (USD Million) Table 11. Global Peptic Ulcers Treatment Key Company Manufacturing Base & Headquarters Table 12. Global Peptic Ulcers Treatment Company, Product Type & Application Table 13. Global Peptic Ulcers Treatment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Peptic Ulcers Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of DWP-14012 Table 18. Significant Companies of DWJ-206 Table 19. Significant Companies of BGC-001 Table 20. Significant Companies of ASP-6537 Table 21. Significant Companies of Others Table 22. Global Peptic Ulcers Treatment Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Peptic Ulcers Treatment Sales Volume by Type (2021-2026) & (k units) Table 24. Global Peptic Ulcers Treatment Sales Volume by Type (2027-2032) & (k units) Table 25. Global Peptic Ulcers Treatment Sales Volume Share by Type (2021-2026) Table 26. Global Peptic Ulcers Treatment Sales Volume Share by Type (2027-2032) Table 27. Global Peptic Ulcers Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Peptic Ulcers Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Peptic Ulcers Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Peptic Ulcers Treatment Sales Value Share by Type (2021-2026) Table 31. Global Peptic Ulcers Treatment Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Peptic Ulcers Treatment Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Peptic Ulcers Treatment Sales Volume by Application (2021-2026) & (k units) Table 37. Global Peptic Ulcers Treatment Sales Volume by Application (2027-2032) & (k units) Table 38. Global Peptic Ulcers Treatment Sales Volume Share by Application (2021-2026) Table 39. Global Peptic Ulcers Treatment Sales Volume Share by Application (2027-2032) Table 40. Global Peptic Ulcers Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Peptic Ulcers Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Peptic Ulcers Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Peptic Ulcers Treatment Sales Value Share by Application (2021-2026) Table 44. Global Peptic Ulcers Treatment Sales Value Share by Application (2027-2032) Table 45. Global Peptic Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Peptic Ulcers Treatment Sales by Region (2021-2026) & (k units) Table 47. Global Peptic Ulcers Treatment Sales Market Share by Region (2021-2026) Table 48. Global Peptic Ulcers Treatment Sales by Region (2027-2032) & (k units) Table 49. Global Peptic Ulcers Treatment Sales Market Share by Region (2027-2032) Table 50. Global Peptic Ulcers Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Peptic Ulcers Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Peptic Ulcers Treatment Sales Value Share by Region (2021-2026) Table 53. Global Peptic Ulcers Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Peptic Ulcers Treatment Sales Value Share by Region (2027-2032) Table 55. Global Peptic Ulcers Treatment Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Peptic Ulcers Treatment Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Peptic Ulcers Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Peptic Ulcers Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Peptic Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 60. Global Peptic Ulcers Treatment Sales Market Share by Country (2021-2026) Table 61. Global Peptic Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 62. Global Peptic Ulcers Treatment Sales Market Share by Country (2027-2032) Table 63. Global Peptic Ulcers Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Peptic Ulcers Treatment Sales Value Market Share by Country (2021-2026) Table 65. Global Peptic Ulcers Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Peptic Ulcers Treatment Sales Value Market Share by Country (2027-2032) Table 67. Ache Laboratorios Farmaceuticos S/A Company Information Table 68. Ache Laboratorios Farmaceuticos S/A Business Overview Table 69. Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Product Portfolio Table 71. Ache Laboratorios Farmaceuticos S/A Recent Development Table 72. Astellas Pharma Inc. Company Information Table 73. Astellas Pharma Inc. Business Overview Table 74. Astellas Pharma Inc. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Astellas Pharma Inc. Peptic Ulcers Treatment Product Portfolio Table 76. Astellas Pharma Inc. Recent Development Table 77. ChoDang Pharm Co., Ltd. Company Information Table 78. ChoDang Pharm Co., Ltd. Business Overview Table 79. ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Product Portfolio Table 81. ChoDang Pharm Co., Ltd. Recent Development Table 82. Daewoong Pharmaceutical Co., Ltd. Company Information Table 83. Daewoong Pharmaceutical Co., Ltd. Business Overview Table 84. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Product Portfolio Table 86. Daewoong Pharmaceutical Co., Ltd. Recent Development Table 87. Kukje Pharmaceutical Industry Co., Ltd. Company Information Table 88. Kukje Pharmaceutical Industry Co., Ltd. Business Overview Table 89. Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Product Portfolio Table 91. Kukje Pharmaceutical Industry Co., Ltd. Recent Development Table 92. RaQualia Pharma Inc. Company Information Table 93. RaQualia Pharma Inc. Business Overview Table 94. RaQualia Pharma Inc. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. RaQualia Pharma Inc. Peptic Ulcers Treatment Product Portfolio Table 96. RaQualia Pharma Inc. Recent Development Table 97. Sequella, Inc. Company Information Table 98. Sequella, Inc. Business Overview Table 99. Sequella, Inc. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Sequella, Inc. Peptic Ulcers Treatment Product Portfolio Table 101. Sequella, Inc. Recent Development Table 102. Sihuan Pharmaceutical Holdings Group Ltd. Company Information Table 103. Sihuan Pharmaceutical Holdings Group Ltd. Business Overview Table 104. Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Product Portfolio Table 106. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development Table 107. Sinil Pharmaceutical Co., Ltd Company Information Table 108. Sinil Pharmaceutical Co., Ltd Business Overview Table 109. Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio Table 111. Sinil Pharmaceutical Co., Ltd Recent Development Table 112. Yooyoung Pharmaceutical Co., Ltd Company Information Table 113. Yooyoung Pharmaceutical Co., Ltd Business Overview Table 114. Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio Table 116. Yooyoung Pharmaceutical Co., Ltd Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Peptic Ulcers Treatment Distributors List Table 120. Peptic Ulcers Treatment Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Peptic Ulcers Treatment Product Image Figure 2. Global Peptic Ulcers Treatment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptic Ulcers Treatment Sales Value (2021-2032) & (US$ Million) Figure 4. Global Peptic Ulcers Treatment Sales (2021-2032) & (k units) Figure 5. Global Peptic Ulcers Treatment Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Peptic Ulcers Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. DWP-14012 Image Figure 10. DWJ-206 Image Figure 11. BGC-001 Image Figure 12. ASP-6537 Image Figure 13. Others Image Figure 14. Global Peptic Ulcers Treatment Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Peptic Ulcers Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Peptic Ulcers Treatment Sales Volume Share by Type (2021-2032) Figure 17. Global Peptic Ulcers Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Peptic Ulcers Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Peptic Ulcers Treatment Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Peptic Ulcers Treatment Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Peptic Ulcers Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Peptic Ulcers Treatment Sales Volume Share by Application (2021-2032) Figure 26. Global Peptic Ulcers Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Peptic Ulcers Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Peptic Ulcers Treatment Sales Value Share by Application (2021-2032) Figure 29. Global Peptic Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Peptic Ulcers Treatment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Peptic Ulcers Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Peptic Ulcers Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Peptic Ulcers Treatment Sales Value (2021-2032) & (US$ Million) Figure 34. North America Peptic Ulcers Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Peptic Ulcers Treatment Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Peptic Ulcers Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Peptic Ulcers Treatment Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Peptic Ulcers Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Peptic Ulcers Treatment Sales Value (2021-2032) & (US$ Million) Figure 40. South America Peptic Ulcers Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Peptic Ulcers Treatment Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Peptic Ulcers Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Peptic Ulcers Treatment Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Peptic Ulcers Treatment Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • DWP-14012
  • DWJ-206
  • BGC-001
  • ASP-6537
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Ache Laboratorios Farmaceuticos S/A
  • Astellas Pharma Inc.
  • ChoDang Pharm Co., Ltd.
  • Daewoong Pharmaceutical Co., Ltd.
  • Kukje Pharmaceutical Industry Co., Ltd.
  • RaQualia Pharma Inc.
  • Sequella, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Sinil Pharmaceutical Co., Ltd
  • Yooyoung Pharmaceutical Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peptic Ulcers Treatment Sales Value (2021-2032)
  4. 1.2.2 Global Peptic Ulcers Treatment Sales Volume (2021-2032)
  5. 1.2.3 Global Peptic Ulcers Treatment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Peptic Ulcers Treatment Market Dynamics
  1. 2.1 Peptic Ulcers Treatment Industry Trends
  2. 2.2 Peptic Ulcers Treatment Industry Drivers
  3. 2.3 Peptic Ulcers Treatment Industry Opportunities and Challenges
  4. 2.4 Peptic Ulcers Treatment Industry Restraints
3 Peptic Ulcers Treatment Market by Company
  1. 3.1 Global Peptic Ulcers Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Peptic Ulcers Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Peptic Ulcers Treatment Sales Volume by Company (2021-2026)
  4. 3.4 Global Peptic Ulcers Treatment Average Price by Company (2021-2026)
  5. 3.5 Global Peptic Ulcers Treatment Company Ranking (2024-2026)
  6. 3.6 Global Peptic Ulcers Treatment Company Manufacturing Base and Headquarters
  7. 3.7 Global Peptic Ulcers Treatment Company Product Type and Application
  8. 3.8 Global Peptic Ulcers Treatment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Peptic Ulcers Treatment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Peptic Ulcers Treatment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Peptic Ulcers Treatment Market by Type
  1. 4.1 Peptic Ulcers Treatment Type Introduction
  2. 4.1.1 DWP-14012
  3. 4.1.2 DWJ-206
  4. 4.1.3 BGC-001
  5. 4.1.4 ASP-6537
  6. 4.1.5 Others
  7. 4.2 Global Peptic Ulcers Treatment Sales Volume by Type
  8. 4.2.1 Global Peptic Ulcers Treatment Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Peptic Ulcers Treatment Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Peptic Ulcers Treatment Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Peptic Ulcers Treatment Sales Value by Type
  12. 4.3.1 Global Peptic Ulcers Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Peptic Ulcers Treatment Sales Value by Type (2021-2032)
  14. 4.3.3 Global Peptic Ulcers Treatment Sales Value Share by Type (2021-2032)
5 Peptic Ulcers Treatment Market by Application
  1. 5.1 Peptic Ulcers Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Peptic Ulcers Treatment Sales Volume by Application
  6. 5.2.1 Global Peptic Ulcers Treatment Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peptic Ulcers Treatment Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Peptic Ulcers Treatment Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Peptic Ulcers Treatment Sales Value by Application
  10. 5.3.1 Global Peptic Ulcers Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Peptic Ulcers Treatment Sales Value by Application (2021-2032)
  12. 5.3.3 Global Peptic Ulcers Treatment Sales Value Share by Application (2021-2032)
6 Peptic Ulcers Treatment Regional Sales and Value Analysis
  1. 6.1 Global Peptic Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peptic Ulcers Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Peptic Ulcers Treatment Sales by Region: 2021-2026
  4. 6.2.2 Global Peptic Ulcers Treatment Sales by Region (2027-2032)
  5. 6.3 Global Peptic Ulcers Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Peptic Ulcers Treatment Sales Value by Region (2021-2032)
  7. 6.4.1 Global Peptic Ulcers Treatment Sales Value by Region: 2021-2026
  8. 6.4.2 Global Peptic Ulcers Treatment Sales Value by Region (2027-2032)
  9. 6.5 Global Peptic Ulcers Treatment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Peptic Ulcers Treatment Sales Value (2021-2032)
  12. 6.6.2 North America Peptic Ulcers Treatment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Peptic Ulcers Treatment Sales Value (2021-2032)
  15. 6.7.2 Europe Peptic Ulcers Treatment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Peptic Ulcers Treatment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Peptic Ulcers Treatment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Peptic Ulcers Treatment Sales Value (2021-2032)
  21. 6.9.2 South America Peptic Ulcers Treatment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Peptic Ulcers Treatment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Peptic Ulcers Treatment Sales Value Share by Country, 2025 VS 2032
7 Peptic Ulcers Treatment Country-level Sales and Value Analysis
  1. 7.1 Global Peptic Ulcers Treatment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Peptic Ulcers Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Peptic Ulcers Treatment Sales by Country (2021-2032)
  4. 7.3.1 Global Peptic Ulcers Treatment Sales by Country (2021-2026)
  5. 7.3.2 Global Peptic Ulcers Treatment Sales by Country (2027-2032)
  6. 7.4 Global Peptic Ulcers Treatment Sales Value by Country (2021-2032)
  7. 7.4.1 Global Peptic Ulcers Treatment Sales Value by Country (2021-2026)
  8. 7.4.2 Global Peptic Ulcers Treatment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Peptic Ulcers Treatment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Peptic Ulcers Treatment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Peptic Ulcers Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ache Laboratorios Farmaceuticos S/A
  2. 8.1.1 Ache Laboratorios Farmaceuticos S/A Company Information
  3. 8.1.2 Ache Laboratorios Farmaceuticos S/A Business Overview
  4. 8.1.3 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Product Portfolio
  6. 8.1.5 Ache Laboratorios Farmaceuticos S/A Recent Developments
  7. 8.2 Astellas Pharma Inc.
  8. 8.2.1 Astellas Pharma Inc. Company Information
  9. 8.2.2 Astellas Pharma Inc. Business Overview
  10. 8.2.3 Astellas Pharma Inc. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Astellas Pharma Inc. Peptic Ulcers Treatment Product Portfolio
  12. 8.2.5 Astellas Pharma Inc. Recent Developments
  13. 8.3 ChoDang Pharm Co., Ltd.
  14. 8.3.1 ChoDang Pharm Co., Ltd. Company Information
  15. 8.3.2 ChoDang Pharm Co., Ltd. Business Overview
  16. 8.3.3 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Product Portfolio
  18. 8.3.5 ChoDang Pharm Co., Ltd. Recent Developments
  19. 8.4 Daewoong Pharmaceutical Co., Ltd.
  20. 8.4.1 Daewoong Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Product Portfolio
  24. 8.4.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Kukje Pharmaceutical Industry Co., Ltd.
  26. 8.5.1 Kukje Pharmaceutical Industry Co., Ltd. Company Information
  27. 8.5.2 Kukje Pharmaceutical Industry Co., Ltd. Business Overview
  28. 8.5.3 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Product Portfolio
  30. 8.5.5 Kukje Pharmaceutical Industry Co., Ltd. Recent Developments
  31. 8.6 RaQualia Pharma Inc.
  32. 8.6.1 RaQualia Pharma Inc. Company Information
  33. 8.6.2 RaQualia Pharma Inc. Business Overview
  34. 8.6.3 RaQualia Pharma Inc. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 RaQualia Pharma Inc. Peptic Ulcers Treatment Product Portfolio
  36. 8.6.5 RaQualia Pharma Inc. Recent Developments
  37. 8.7 Sequella, Inc.
  38. 8.7.1 Sequella, Inc. Company Information
  39. 8.7.2 Sequella, Inc. Business Overview
  40. 8.7.3 Sequella, Inc. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sequella, Inc. Peptic Ulcers Treatment Product Portfolio
  42. 8.7.5 Sequella, Inc. Recent Developments
  43. 8.8 Sihuan Pharmaceutical Holdings Group Ltd.
  44. 8.8.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
  45. 8.8.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
  46. 8.8.3 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Product Portfolio
  48. 8.8.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
  49. 8.9 Sinil Pharmaceutical Co., Ltd
  50. 8.9.1 Sinil Pharmaceutical Co., Ltd Company Information
  51. 8.9.2 Sinil Pharmaceutical Co., Ltd Business Overview
  52. 8.9.3 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
  54. 8.9.5 Sinil Pharmaceutical Co., Ltd Recent Developments
  55. 8.10 Yooyoung Pharmaceutical Co., Ltd
  56. 8.10.1 Yooyoung Pharmaceutical Co., Ltd Company Information
  57. 8.10.2 Yooyoung Pharmaceutical Co., Ltd Business Overview
  58. 8.10.3 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
  60. 8.10.5 Yooyoung Pharmaceutical Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Peptic Ulcers Treatment Value Chain Analysis
  2. 9.1.1 Peptic Ulcers Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Peptic Ulcers Treatment Sales Mode & Process
  6. 9.2 Peptic Ulcers Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Peptic Ulcers Treatment Distributors
  9. 9.2.3 Peptic Ulcers Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst